Interleukin-6 and JAK 2 / STAT 3 signaling mediate the reversion of dexamethasone resistance after dexamethasone withdrawal in 7 TD 1 multiple myeloma cells

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• [New drugs in the treatment of multiple myeloma].

  2014cited by this paper
• Dexamethasone-induced apoptosis and up-regulation of Bim is dependent on glycogen synthase kinase-3.

  2009cited by this paper
• Withdrawal of Sex Steroids Reverses Age- and Chemotherapy-Related Defects in Bone Marrow Lymphopoiesis1

  2009cited by this paper
• Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants.

  2008cited by this paper
• Apoptotic resistance exhibited by dexamethasone-resistant murine 7TD1 cells is controlled independently of interleukin-6 triggered signaling

  2008influential reference
• Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors.

  2008cited by this paper
• The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies.

  2007cited by this paper
• Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor.

  2005cited by this paper
• The role of the bone marrow microenvironment in multiple myeloma.

  2005cited by this paper
• Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside

  2005cited by this paper
• PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells

  2004cited by this paper
• Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance

  2004cited by this paper
• Inhibition of Glucocorticoid-induced Apoptosis by Targeting the Major Splice Variants of BIM mRNA with Small Interfering RNA and Short Hairpin RNA*

  2004cited by this paper
• Dexamethasone-induced thymocytes apoptosis requires glucocorticoid receptor nuclear translocation but not mitochondrial membrane potential transition.

  2003cited by this paper
• Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation.

  2003cited by this paper
• Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells.

  2003cited by this paper
• Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells.

  2003cited by this paper
• Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

  2003cited by this paper
• Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex

  2003cited by this paper
• In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway.

  2002cited by this paper
• Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies.

  2002cited by this paper
• Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis.

  2001cited by this paper
• Interleukin 6 and Haemostasis

  2001cited by this paper
• Multiple Myeloma: An Old Disease with New Hope for the Future

  2001cited by this paper
• Cyclic AMP- and IL6-signaling cross talk: comodulation of proliferation and apoptosis in the 7TD1 B cell hybridoma.

  2001cited by this paper
• Reversal of Anticancer Drug Resistance by Macrolide Antibiotics in Vitro and in Vivo

  2000cited by this paper
• Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell.

  2000cited by this paper
• SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells.

  2000cited by this paper
• Polyamine-depletion induces p27Kip1 and enhances dexamethasone-induced G1 arrest and apoptosis in human T lymphoblastic leukemia cells.

  2000cited by this paper
• JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.

  1999influential reference
• Bcl-2 overexpression is associated with resistance to dexamethasone, but not melphalan, in multiple myeloma cells.

  1998cited by this paper
• Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: support for the hypothesis that protection is mediated via inhibition of the JNK/SAPK pathway.

  1998cited by this paper
• Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

  1998cited by this paper
• Interleukin‐6: Structure‐function relationships

  1997cited by this paper
• Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms

  1997cited by this paper
• IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.

  1997cited by this paper
• Interleukin-6 overcomes p21WAF1 upregulation and G1 growth arrest induced by dexamethasone and interferon-gamma in multiple myeloma cells.

  1997cited by this paper
• Assessment of the ATP Binding Properties of Hsp90 (*)

  1996cited by this paper
• A novel action of glucocorticoids--NF-kappa B inhibition.

  1996cited by this paper
• Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

  1996cited by this paper
• The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family

  1994cited by this paper
• Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor.

  1994cited by this paper
• Molecular cloning and expression of an IL-6 signal transducer, gp130.

  1990cited by this paper
• Down-regulation of glucocorticoid receptor mRNA by glucocorticoid hormones and recognition by the receptor of a specific binding sequence within a receptor cDNA clone.

  1986cited by this paper
• Glucocorticoid receptors: relations between steroid binding and biological effects.

  1972cited by this paper
• THE TREATMENT OF MULTIPLE MYELOMA

  1948cited by this paper

• Enhancement of ICAM-1 via the JAK2/STAT3 signaling pathway in a rat model of severe acute pancreatitis-associated lung injury

  2016cites this paper